2024 U.S. POC/Decentralized Testing Markets: Country Supplier Shares, Test Volume and Sales Segment Forecasts

August 2024 | | ID: 2B14BE779495EN
Venture Planning Group

Abstracts

This report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.; This report will help diagnostic instrument and reagent suppliers develop more effective business, R&D and marketing strategies.RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis%li%Review of the emerging POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.%li%Five-year test volume and reagent sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:%li%Cancer Clinics%li%Ambulatory Care Centers%li%Surgery Centers%li%Nursing Homes%li%Birth Centers and by test category:%li%Routine and Special Chemistry%li%Microbiology/Infectious Diseases %li%Hematology%li%Flow Cytometry %li%Coagulation%li%Immunoproteins%li%Drugs of Abuse%li%TDM%li%Endocrine Function%li%Tumor MarkersSales and Market Share Analysis%li%Sales and market shares of major reagent and instrument suppliers.Current and Emerging Products%li%Analysis of over 130 diagnostic procedures.%li%Review of the leading POC chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.Technology Review%li%Emerging technologies and their applications for POC testing.%li%Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.Competitive Assessments%li%Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.Strategic Recommendations%li%Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.%li%Design criteria for POC testing products.%li%Alternative business expansion strategies.%li%Potential market entry barriers and risks.MethodologyThis report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contents

I. Introduction
II. Hepatitis Worldwide Market and Technology Overview
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C

0 CLASSIFICATION

0 TRANSMISSION OF INFECTION

0 OCCUPATIONAL HAZARDS

0 ACUTE HEPATITIS

0 DIAGNOSIS OF ACUTE INFECTION

0 CHRONIC HEPATITIS

0 HCV AND OTHER CHRONIC LIVER DISEASES

0 ALCOHOLIC LIVER DISEASE

0 HEPATITIS B COINFECTION

0 CIRRHOSIS AND HEPATOCELLULAR CARCINOMA

0 DIAGNOSTIC TESTS

0 POSSIBLE INDICATIONS FOR HCV RNA TESTING

0 CONCLUSIONS AND FUTURE DIRECTION

E. Hepatitis D

0 HISTORICAL PERSPECTIVE

0 EPIDEMIOLOGY

0 HBV-HDV 'COINFECTION' VS. 'SUPERINFECTION'

0 METHODS OF DETECTING HDV

0 PREVENTION

F. Hepatitis E

0 BACKGROUND

0 PREVALENCE OF THE DISEASE

0 DIAGNOSTIC TESTS

0 EPIDEMIOLOGIC SEROSURVEYS

0 SEROLOGIC CROSS-REACTIVITY

G. Hepatitis G

0 VACCINES AND DRUGS

Table of Contents (continued)
H. Review of Leading Analyzers Marketed by: Abbott, Beckman
Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche,
Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies

1. MOLECULAR DIAGNOSTICS

2. MONOCLONAL ANTIBODIES

3. IMMUNOASSAYS

4. DIFFERENTIAL LIGHT SCATTERING

5. INFORMATION TECHNOLOGY

6. ARTIFICIAL INTELLIGENCE

7. LIPOSOMES

8. FLOW CYTOMETRY

9. CHROMATOGRAPHY

10. DIAGNOSTIC IMAGING

11. GEL MICRODROPLETS

12. OTHER

III. Country: Market Size, Growth and Major Suppliers’
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

1. MARKETING APPROACHES

2. PRODUCT COMPLEXITY

3. CUSTOMER PREFERENCE

4. ESTABLISHED SUPPLIERS

5. EMERGING SUPPLIERS

6. MAJOR TYPES OF DISTRIBUTORS

7. MARKET SEGMENTATION